DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 06 · Volume 58 · November 2025 DOI: 10.1055/s-015-62503

Review

  • 249
    Kishi, Taro; Citrome, Leslie; Sakuma, Kenji; Hamanaka, Shun; Nishii, Yasufumi; Hatano, Masakazu; Furukawa, Osamu; Saito, Youichi; Iwata, Nakao:

    Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes

    Supplementary Material (PDF)
  • 255
    Liu, Tingting; Shi, Fuqiang; Guo, Zhihua; Li, Hongwu; Qin, Di:

    Therapeutic Potential of the Novel GLP-1 Receptor Agonist Semaglutide in Alcohol Use Disorder

    • Original Paper

  • 263
    Kuzo, Nazar; Piras, Marianna; Lutz, Ulrich C.; Haen, Ekkehard; Eap, Chin B.; Hiemke, Christoph; Paulzen, Michael; Schoretsanitis, Georgios:

    Therapeutic Reference Range for Clozapine Plasma Levels in Parkinson’s Disease or Dementia: A Systematic Review and Individual Participant Data Meta-analysis

    Supplementary Material (PDF)
  • 273
    Dormegny-Jeanjean, Ludovic C.; Lenoir, Suzie; Humbert, Ilia; Mainberger, Olivier A. E.; Lozere, Coraline; Meyer, Camille; Geny, Bernard; Michel, Bruno; Foucher, Jack R.; de Crespin de Billy, Clément:

    Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Bayesian Analyses

    Supplementary Material (PDF)
  • 285
    Kurt, Gizem; Durhan, Seyda T.; Ak, Mehmet; Yanik, Tulin:

    Time-Dependent Effects of Metformin and Olanzapine on the Metabolic System

    Supplementary Material (PDF)